Intellipharmaceutics International Inc. (IPCI)

[fmgrana]

Doog, from the company's site, the rexista formulation is differentiated from Perdue's oxycontin in the following ways. Just to clarify the distinction so the article isn't as confusing to some...

The pilot clinical trial produced the following results:

The Rexista™ product demonstrated sustained release pharmacokinetic activity, with blood plasma concentrations at clinically significant levels over a 24 hour period.
The bioavailability of a single dose of the Rexista™ product, as measured by Cmax and AUC, was comparable to that of two doses of OxyContin® dosed at 12 hour intervals. Both Cmax and AUC were in the 80% - 125% range as compared to OxyContin®, demonstrating effective bioequivalence with the branded product.